Abstract
The purpose of this study is to investigate the association of IκBα with the development of ankylosing spondylitis (AS) in Taiwan. One hundred and fifty-four patients with AS and 112 unrelated healthy controls were enrolled in this study. The IκBα-881A/G, -826C/T, -550A/T, -519C/T, and -297C/T polymorphisms were determined by the polymerase chain reaction/restriction fragment length polymorphism method. This study demonstrated that the genotype frequencies of IκBα-826C/T and -826T/T, and allele frequencies of IκBα-826T were significantly higher in the patients with AS than in the controls. We also found that the estimated haplotype frequencies of IκBα-881A -826T -550A -519C -297C and IκBα-881A -826C -550A -519T -297C were significantly increased in the patient with AS in comparison with that of the controls. In contrast, the estimated haplotype frequency of IκBα-881A -826C -550A -519C -297C was significantly decreased in the patients with AS. This study demonstrates that IκBα-826T is associated with the development of AS. Furthermore, the IκBα-881A -826T -550A -519C -297C and IκBα-881A -826C -550A -519T -297C haplotypes are related to susceptibility to AS in Taiwan.
Similar content being viewed by others
References
Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390. doi:10.1016/S0140-6736(07)60635-7
Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40:1823–1828. doi:10.1002/art.1780401015
van der Linden SM, Valkenburg HA, de Jongh BM, Cats A (1984) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27:241–249. doi:10.1002/art.1780270301
Brown MA (2006) Non-major-histocompatibility-complex genetics of ankylosing spondylitis. Best Pract Res Clin Rheumatol 20:611–621. doi:10.1016/j.berh.2006.03.005
Brown MA (2007) Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology (Oxford) 47:132–137
Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ et al (2007) Association Scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39:1329–1337. doi:10.1038/ng.2007.17
Carter KW, Pluzhnikov A, Timms AE, Miceli-Richard C, Bourgain C, Wordsworth BP, Jean-Pierre H, Cox NJ, Palmer LJ, Breban M et al (2007) Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology (Oxford) 46:763–771. doi:10.1093/rheumatology/kel443
Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks DE, Calin A et al (2001) Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 68:918–926. doi:10.1086/319509
Yen JH, Tsai WC, Chen CJ, Lin CH, Ou TT, Hu CJ, Liu HW (2003) Cytochrome P450 1a1 and manganese superoxide dismutase genes polymorphisms in ankylosing spondylitis. Immunol Lett 88:113–116. doi:10.1016/S0165-2478(03)00071-3
Barnes PJ, Karin M (1997) Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071. doi:10.1056/NEJM199704103361506
Baeuerle PA (1998) Pro-inflammatory signaling: last pieces in the NF-Kappa B puzzle? Curr Biol 8:R19–R22. doi:10.1016/S0960-9822(98)70010-7
Tak PP, Firestein GS (2001) NF-KappaB: a key role in inflammatory diseases. J Clin Invest 107:7–11. doi:10.1172/JCI11830
Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I (2002) NF-Kappa B regulation in human neutrophils by nuclear I Kappa B alpha: correlation to apoptosis. J Immunol 169:3947–3953
Campbell IK, Gerondakis S, O’Donnell K, Wicks IP (2000) Distinct roles for the NF-Kappa B1 (P50) and C-Rel transcription factors in inflammatory arthritis. J Clin Invest 105:1799–1806. doi:10.1172/JCI8298
May MJ, Ghosh S (1997) Rel/NF-Kappa B and I Kappa B proteins: an overview. Semin Cancer Biol 8:63–73. doi:10.1006/scbi.1997.0057
Whiteside ST, Israel A (1997) I Kappa B proteins: structure, function and regulation. Semin Cancer Biol 8:75–82. doi:10.1006/scbi.1997.0058
Mozzato-Chamay N, Corbett EL, Bailey RL, Mabey DC, Raynes J, Conway DJ (2001) Polymorphisms in the I kappa B-alpha promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun 2:153–155. doi:10.1038/sj.gene.6363753
Ito CY, Kazantsev AG, Baldwin AS Jr (1994) Three NF-Kappa B sites in the I Kappa B-alpha promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res 22:3787–3792. doi:10.1093/nar/22.18.3787
Lin CH, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH (2007) I Kappa B alpha promoter polymorphisms in patients with rheumatoid arthritis. Int J Immunogenet 34:51–54. doi:10.1111/j.1744-313X.2007.00660.x
Lin CH, Wang SC, Ou TT, Li RN, Tsai WC, Liu HW, Yen JH (2008) I Kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus. J Clin Immunol 28:207–213. doi:10.1007/s10875-007-9156-1
Ou TT, Lin CH, Lin YC, Li RN, Tsai WC, Liu HW, Yen JH (2008) I Kappa B alpha promoter polymorphisms in patients with primary Sjogren’s Syndrome. J Clin Immunol 28:440–444. doi:10.1007/s10875-008-9212-5
Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT (1995) Inducible nuclear expression of newly synthesized I Kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-Kappa B. Mol Cell Biol 15:2689–2696
Turpin P, Hay RT, Dargemont C (1999) Characterization of I Kappa B alpha nuclear import pathway. J Biol Chem 274:6804–6812. doi:10.1074/jbc.274.10.6804
Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, Dargemont C (1997) Nuclear localization of I Kappa B alpha promotes active transport of NF-Kappa B from the nucleus to the cytoplasm. J Cell Sci 110(Pt 3):369–378
Ernst MK, Dunn LL, Rice NR (1995) The pest-like sequence of I Kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of C-Rel or Rela homodimers. Mol Cell Biol 15:872–882
Miterski B, Bohringer S, Klein W, Sindern E, Haupts M, Schimrigk S, Epplen JT (2002) Inhibitors in the NF kappa B cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immun 3:211–219. doi:10.1038/sj.gene.6363846
Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, Schmiegel WH, Griga T (2004) A polymorphism of the NFKB IA gene is associated with Crohn’s Disease patients lacking a predisposing allele of the card15 gene. Int J Colorectal Dis 19:153–156. doi:10.1007/s00384-003-0531-y
Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, Arbman G, Wang ZL, Jia CR, Carstensen J, Sun XF (2007) Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand J Gastroenterol 42:345–350. doi:10.1080/00365520600880856
Sun XF, Zhang H (2007) Nfkb and Nfkbi polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 22:1387–1398
Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, van den Bosch JM, Wells AU, du Bois RM, Welsh KI (2003) Inhibitor Kappa B-Alpha (I Kappa B-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun 4:450–454. doi:10.1038/sj.gene.6364001
Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H et al (1999) Overexpression of I Kappa B alpha without inhibition of NF-Kappa B activity and mutations in the I Kappa B alpha gene in Reed–Sternberg cells. Blood 94:3129–3134
Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT (1999) Mutations in the IKBA gene in Hodgkin’s Disease suggest a tumour suppressor role for I Kappa B alpha. Oncogene 18:3063–3070. doi:10.1038/sj.onc.1202893
Beg AA, Sha WC, Bronson RT, Baltimore D (1995) Constitutive NF-Kappa B activation, enhanced granulopoiesis, and neonatal lethality in I Kappa B alpha-deficient mice. Genes Dev 9:2736–2746. doi:10.1101/gad.9.22.2736
Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, Chen CH, Rosen CA, Stewart CL (1996) I Kappa B alpha deficiency results in a sustained NF-Kappa B response and severe widespread dermatitis in mice. Mol Cell Biol 16:2341–2349
Acknowledgments
Part of this laboratory work was supported by a grant from CAPCO Cultural and Educational Foundation.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hung, YH., Ou, TT., Lin, CH. et al. IkBα promoter polymorphisms in patients with ankylosing spondylitis. Rheumatol Int 30, 93–97 (2009). https://doi.org/10.1007/s00296-009-0923-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0923-6